> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# SciGen Recalls Irbesartan for Contamination Potential
- URL: https://www.fdaweb.com/scigen-recalls-irbesartan-for-contamination-potential/
- Published: 2018-10-31T12:00:00.000Z
- Updated: 2026-09-15T00:41:37.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5142715

FDA says that SciGen is recalling specific lots of its hypertension medicine irbesartan for a potential cancer risk due to contamination. The agency says that the recalled lot will have “Westminster Pharmaceuticals” and “GSMS Inc.” on the label. A CNN [story](https://www.cnn.com/2018/10/31/health/fda-recall-heart-drug-irbesartan-bn/index.html?ref=fdaweb.com) also discusses the recent recall of some drugs containing valsartan due to contamination.